We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
158 hedge funds and large institutions have $342M invested in Zevra Therapeutics in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 52 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
145% more call options, than puts
Call options by funds: $28M | Put options by funds: $11.4M
15% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 52
3.32% less ownership
Funds ownership: 71.08% → 67.76% (-3.3%)
5% less funds holding
Funds holding: 166 → 158 (-8)
10% less capital invested
Capital invested by funds: $379M → $342M (-$37.7M)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
158
Holders Change
-8
Holders Change %
-4.82%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
60
Reduced
52
Closed
30
Calls
$28M
Puts
$11.4M
Net Calls
+$16.6M
Net Calls Change
+$4.51M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.18M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6.16M |
| 3 |
Morgan Stanley
New York
|
+$5.69M |
| 4 |
BlackRock
New York
|
+$4.44M |
| 5 |
Jane Street
New York
|
+$3.31M |
